Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients.
Di-Han LiuZheng-Hao YeSi ChenXue-Song SunJing-Yu HouZe-Rui ZhaoHao LongPublished in: Journal of cancer research and clinical oncology (2019)
An integrated prognostic model was developed to discriminate resected stage I adenocarcinoma patients into low- and high-risk groups, which will help clinicians select individual treatment strategies.